Cargando…
Elevating local concentrations of GPIIb–IIIa antagonists counteracts platelet thrombus stability
Glycoprotein IIb–IIIa (GPIIb–IIIa) antagonists have the capacity to destabilize coronary thrombi and restore vessel patency. Antagonist concentration and residence time, which can be increased by local intracoronary (LIC) administration, and thrombus age may be key factors that influence thrombus st...
Autores principales: | Speich, Henry E., Furman, Ronit R., Lands, Lindsey T., Moodie, Geoffrey D., Jennings, Lisa K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682094/ https://www.ncbi.nlm.nih.gov/pubmed/23073747 http://dx.doi.org/10.1007/s11239-012-0814-7 |
Ejemplares similares
-
The GPIIb-IIIa defect of platelets in Glanzmann thrombasthenia
por: Nurden, Alan T.
Publicado: (2023) -
Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation
por: Curry, Benjamin J., et al.
Publicado: (2023) -
Biosynthesis and processing of platelet GPIIb-IIIa in human megakaryocytes
Publicado: (1987) -
Evidence for the selective association of a subpopulation of GPIIb-IIIa with the actin cytoskeletons of thrombin-activated platelets
Publicado: (1993) -
Functional Comparison of Induced Pluripotent Stem Cell- and Blood-Derived GPIIbIIIa Deficient Platelets
por: Orban, Mathias, et al.
Publicado: (2015)